홈 › 두경부 편평세포암 › 일리노이

일리노이의 두경부 편평세포암 임상 시험

두경부 편평세포암 관련 연구 33개가 일리노이 내 여러 지역에서 참여자를 모집하고 있습니다.

일리노이의 도시

공식 연구 텍스트(영어)

Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma

Northwestern University, Chicago
John H Stroger Jr Hospital of Cook County, Chicago
University of Illinois, Chicago
외 14개

피험자 모집 중2상

18세 ~ 79세 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT04671667

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

Illinois CancerCare-Bloomington, Bloomington
Illinois CancerCare-Canton, Canton
Illinois CancerCare-Carthage, Carthage
외 36개

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT05136196

Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment

Advocate Good Shepherd Hospital, Barrington
University of Chicago Comprehensive Cancer Center, Chicago
Advocate Illinois Masonic Medical Center, Chicago
외 27개

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT06589804

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

University of Illinois Cancer Center, Chicago

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 11. 6. 업데이트됨 · NCT04198766

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

University of Chicago Hospital, Chicago

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT06465069

High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer

Advocate Outpatient Center - Aurora, Aurora
Advocate Good Shepherd Hospital, Barrington
Illinois CancerCare-Bloomington, Bloomington
외 40개

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT06992427

A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancer

The University of Chicago Medical Center (UCMC), Chicago

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 11. 3. 업데이트됨 · NCT06385080

A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer

Rush University Medical Center Rush University Cancer Center Chicago, Chicago
The University of Chicago Medical Center (UCMC), Chicago
Cancer Care Specialists of Central Illinois, O'Fallon

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 11. 3. 업데이트됨 · NCT07276399

FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC

Captain James A Lovell Federal Health Care Center-VA North Chicago (Site # 133), Chicago

피험자 모집 중2/3상

18세 이상 · 모든 성별 · 2026. 10. 29. 업데이트됨 · NCT06788990

A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

City of Hope, Chicago, Zion

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 10. 28. 업데이트됨 · NCT07109726

Ordastobart (INBRX-106) Add-on to Pembrolizumab in 1L HPV+ PD-L1+ R/M OPSCC (HexAgon-HN)

University of Illinois Cancer Center, Chicago

피험자 모집 중2/3상

18세 이상 · 모든 성별 · 2026. 10. 28. 업데이트됨 · NCT06295731

A Study to Investigate ALE.P02 as a Monotherapy or in Combination With Pembrolizumab in Adult Patients With Selected CLDN1+ Solid Tumors

The University of Chicago Medical Center - Oncology, Chicago

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 10. 28. 업데이트됨 · NCT06747585

A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

Orchard Healthcare Research Inc, Skokie

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 10. 26. 업데이트됨 · NCT06330064

A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Northwestern University, Evanston

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 10. 22. 업데이트됨 · NCT06769698

SMP-3124LP in Adults With Advanced Solid Tumors

Northwestern Medicine Cancer Center, Chicago
The University of Chicago, Chicago

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 10. 15. 업데이트됨 · NCT06526819

Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400

Northwestern Medicine - Northwestern Memorial Hospital /ID# 257378, Chicago
University of Chicago Medical Center /ID# 258197, Chicago

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 10. 14. 업데이트됨 · NCT06084481

A Study to Evaluate CRB-701 Compared to Investigator's Choice Therapy in Previously Treated Oropharyngeal Squamous Cell Carcinoma

University of Chicago, Chicago

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 10. 8. 업데이트됨 · NCT07768189

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

Exelixis Clinical Site #26, Chicago

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 10. 1. 업데이트됨 · NCT05176483

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

Northwestern University Feinberg School of Medicine, Chicago

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 9. 21. 업데이트됨 · NCT05983432

Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery

OSF Saint Anthony's Health Center, Alton
Rush-Copley Medical Center, Aurora
Advocate Good Shepherd Hospital, Barrington
외 53개

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 9. 14. 업데이트됨 · NCT02734537

A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)

Northwestern University Feinberg School of Medicine, Chicago
Cancer Care Specialists of Illinois, Decatur
Illinois Cancer Care, Peoria

피험자 모집 중관찰 연구

18세 이상 · 모든 성별 · 2026. 9. 3. 업데이트됨 · NCT06163534

A Study to Assess the Adverse Events, Change in Disease Activity, and How Oral ABBV-711 Tablets Move Through the Body as a Monotherapy and in Combination With Intravenously Infused Budigalimab (ABBV-181), in Adults With Advanced Squamous Tumors

University of Chicago Medical Center /ID# 276638, Chicago

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 8. 19. 업데이트됨 · NCT07241039

Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer

Northwestern University, Chicago
Rush MD Anderson Cancer Center, Chicago

피험자 모집 중2/3상

18세 이상 · 모든 성별 · 2026. 8. 17. 업데이트됨 · NCT04333537

Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer

OSF Saint Joseph Medical Center, Bloomington
Illinois CancerCare-Bloomington, Bloomington
Illinois CancerCare-Canton, Canton
외 21개

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 8. 17. 업데이트됨 · NCT06532279

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

Ingalls Family Care Center, Calumet City
UChicago Medicine - River East, Chicago
The University Of Chicago, Chicago
외 13개

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 7. 6. 업데이트됨 · NCT04389632

Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan

University of Illinois Hospital and Health Sciences System /ID# 251750, Chicago
University of Chicago Medical Center /ID# 276271, Chicago

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 6. 23. 업데이트됨 · NCT05005403

A Study of Pembrolizumab in Combination With Chemotherapy for Head and Neck Cancer

University of Chicago Comprehensive Cancer Center, Chicago

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 5. 12. 업데이트됨 · NCT05420948

A Study Evaluating the Safety and Efficacy of PRV111, PRV211, and PRV131 in Subjects With Oral and Lung Cancers

The University of Chicago, Chicago

피험자 모집 중2/3상

18세 ~ 100세 · 모든 성별 · 2026. 4. 23. 업데이트됨 · NCT05893888

A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma

University of Illinois Cancer Center, Chicago

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 4. 9. 업데이트됨 · NCT06064877

Dosing Study of Radiation Combined With Tislelizumab and Pamiparib in Patients With Previously Treated Head and Neck Cancer

The University of Chicago, Chicago

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 3. 4. 업데이트됨 · NCT05526924

A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

The University of Chicago Comprehensive Cancer Center, Chicago

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 2. 13. 업데이트됨 · NCT06778863

A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer

Kellogg Cancer Center, Evanston

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2025. 11. 4. 업데이트됨 · NCT05902988

A Study of NX-1607 in Adults With Advanced Malignancies

University of Chicago, Chicago

피험자 모집 중1상

18세 이상 · 모든 성별 · 2025. 9. 9. 업데이트됨 · NCT05107674

ClinicalTrials.gov 출처, 2026. 11. 15. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.